LTRN
Lantern Pharma (LTRN)
$35
About Lantern Pharma (LTRN)
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Details
Daily high
$4.45
Daily low
$4.10
Price at open
$4.45
52 Week High
$11.99
52 Week Low
$2.79
Market cap
48.3M
Dividend yield
0.00%
Volume
46,807
Avg. volume
74,182
P/E ratio
-2.53
Lantern Pharma News
Details
Daily high
$4.45
Daily low
$4.10
Price at open
$4.45
52 Week High
$11.99
52 Week Low
$2.79
Market cap
48.3M
Dividend yield
0.00%
Volume
46,807
Avg. volume
74,182
P/E ratio
-2.53